Compugen Ltd.
CGEN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.40 | 0.20 | 0.38 | -0.98 |
| FCF Yield | 36.13% | -20.57% | -56.49% | -6.36% |
| EV / EBITDA | -8.45 | -13.00 | -1.59 | -10.31 |
| Quality | ||||
| ROIC | -15.63% | -13.58% | -42.69% | -30.28% |
| Gross Margin | 71.54% | 94.01% | 87.00% | 88.67% |
| Cash Conversion Ratio | -3.49 | 1.91 | 1.02 | 0.67 |
| Growth | ||||
| Revenue 3-Year CAGR | 54.88% | 77.33% | 55.36% | 1,817,020.59% |
| Free Cash Flow Growth | 237.24% | -3.04% | -51.87% | 19.11% |
| Safety | ||||
| Net Debt / EBITDA | 1.06 | 1.00 | 0.28 | 0.15 |
| Interest Coverage | -437.97 | -419.10 | -1,310.15 | -1,402.96 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -81.08 | 31.07 | -648.31 | -2,468.95 |